EICHOR
● Completed
A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
Condition: Plaque Psoriasis · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of the study is to evaluate the efficacy of an oral tablet formulation of JNJ-77242113 compared with placebo in participants with moderate-to-severe plaque psoriasis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (34)
| Stoll Dermatology | Beverly Hills, California, United States | — |
| Northshore University Healthsystem | Skokie, Illinois, United States | — |
| Epiphany Dermatology of Kansas, LLC | Overland Park, Kansas, United States | — |
| Dermatology Specialists | Louisville, Kentucky, United States | — |
| Lawrence J Green MD LLC | Rockville, Maryland, United States | — |
| ActivMed Practices and Research | Beverly, Massachusetts, United States | — |
| ActivMed Practices and Research | Portsmouth, New Hampshire, United States | — |
| Windsor Dermatology, PC | East Windsor, New Jersey, United States | — |
| Unity Clinical Research | Oklahoma City, Oklahoma, United States | — |
| The Pennsylvania Centre for Dermatology, LLC | Exton, Pennsylvania, United States | — |
| Health Concepts | Rapid City, South Dakota, United States | — |
| Arlington Center for Dermatology | Arlington, Texas, United States | — |
+ 22 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05357755